BRANDI DOBBS: Open Payments
NPI 1255454500 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 23 payments from 12 companies in 2025. Trend: 2023 $266 · 2024 $979 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $405 |
| Madrigal Pharmaceuticals | 3 | $191 |
| Sequel Med Tech, LLC | 1 | $150 |
| Corcept Therapeutics | 1 | $118 |
| Mannkind Corporation | 3 | $62 |
| Abbott Laboratories | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| KYOWA KIRIN, INC. | 1 | $21 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Wegovy, REZDIFFRA, TWIIST, Korlym, AFREZZA, FREESTYLE LIBRE 3, TZIELD, Ozempic.
Industry payments across OH — which companies pay providers there.
